Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.

Guiu B, Deschamps F, Aho S, Munck F, Dromain C, Boige V, Malka D, Leboulleux S, Ducreux M, Schlumberger M, Baudin E, de Baere T.

J Hepatol. 2012 Mar;56(3):609-17. doi: 10.1016/j.jhep.2011.09.012. Epub 2011 Oct 23.

PMID:
22027582
[PubMed - indexed for MEDLINE]
2.

Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations.

Lencioni R, de Baere T, Burrel M, Caridi JG, Lammer J, Malagari K, Martin RC, O'Grady E, Real MI, Vogl TJ, Watkinson A, Geschwind JF.

Cardiovasc Intervent Radiol. 2012 Oct;35(5):980-5. Epub 2011 Oct 19. Review.

PMID:
22009576
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis.

Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Arrese D, Ferrero A, Schulick RD, Choti MA, Geschwind JF, Strub J, Bauer TW, Adams RB, Aldrighetti L, Mentha G, Capussotti L, Pawlik TM.

Ann Surg Oncol. 2011 Dec;18(13):3657-65. doi: 10.1245/s10434-011-1832-y. Epub 2011 Jun 17.

PMID:
21681380
[PubMed - indexed for MEDLINE]
4.

Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.

Gaur SK, Friese JL, Sadow CA, Ayyagari R, Binkert CA, Schenker MP, Kulke M, Baum R.

Cardiovasc Intervent Radiol. 2011 Jun;34(3):566-72. doi: 10.1007/s00270-011-0122-1. Epub 2011 Mar 24.

PMID:
21431978
[PubMed - indexed for MEDLINE]
5.

Surgical management and emerging therapies to prolong survival in metastatic neuroendocrine cancer.

Mayo SC, de Jong MC, Pawlik TM.

Ann Surg Oncol. 2011 Dec;18 Suppl 3:S220-1; author reply S222-3. doi: 10.1245/s10434-010-1343-2. Epub 2010 Sep 17. No abstract available.

PMID:
20848222
[PubMed - indexed for MEDLINE]
6.

Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis.

De Jong MC, Farnell MB, Sclabas G, Cunningham SC, Cameron JL, Geschwind JF, Wolfgang CL, Herman JM, Edil BH, Choti MA, Schulick RD, Nagorney DM, Pawlik TM.

Ann Surg. 2010 Jul;252(1):142-8. doi: 10.1097/SLA.0b013e3181dbb7a7.

PMID:
20531007
[PubMed - indexed for MEDLINE]
7.

Intra-arterial therapies for hepatocellular carcinoma: where do we stand?

Liapi E, Geschwind JF.

Ann Surg Oncol. 2010 May;17(5):1234-46. doi: 10.1245/s10434-010-0977-4. Epub 2010 Apr 20. Review.

PMID:
20405328
[PubMed - indexed for MEDLINE]
8.

Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Nakashima Y, Ikeno H, Orito N, Notsumata K, Watanabe H, Toya D, Tanaka N, Matsui O.

Cardiovasc Intervent Radiol. 2010 Dec;33(6):1168-79. doi: 10.1007/s00270-009-9781-6. Epub 2010 Jan 8.

PMID:
20058008
[PubMed - indexed for MEDLINE]
9.

Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF.

Cancer J. 2009 Nov-Dec;15(6):526-32. doi: 10.1097/PPO.0b013e3181c5214b.

PMID:
20010173
[PubMed - indexed for MEDLINE]
10.

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.

Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T, Moschouris H, Emmanouil E, Rizos S, Kelekis D.

Cardiovasc Intervent Radiol. 2010 Jun;33(3):541-51. doi: 10.1007/s00270-009-9750-0. Epub 2009 Nov 24.

PMID:
19937027
[PubMed - indexed for MEDLINE]
11.

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P, Lencioni R; PRECISION V Investigators.

Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52. doi: 10.1007/s00270-009-9711-7. Epub 2009 Nov 12.

PMID:
19908093
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.

Vogl TJ, Gruber T, Naguib NN, Hammerstingl R, Nour-Eldin NE.

AJR Am J Roentgenol. 2009 Oct;193(4):941-7. doi: 10.2214/AJR.08.1879.

PMID:
19770314
[PubMed - indexed for MEDLINE]
13.

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF.

Radiology. 2009 Feb;250(2):466-73. doi: 10.1148/radiol.2502072222.

PMID:
19188315
[PubMed - indexed for MEDLINE]
14.

Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?

Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC.

J Gastrointest Surg. 2009 Mar;13(3):486-91. doi: 10.1007/s11605-008-0727-0. Epub 2008 Oct 30.

PMID:
18972167
[PubMed - indexed for MEDLINE]
15.

National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP.

Prev Chronic Dis. 2008 Jul;5(3):A74. Epub 2008 Jun 15.

PMID:
18558024
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.

de Baere T, Deschamps F, Teriitheau C, Rao P, Conengrapht K, Schlumberger M, Leboulleux S, Baudin E, Hechellhammer L.

J Vasc Interv Radiol. 2008 Jun;19(6):855-61. doi: 10.1016/j.jvir.2008.01.030. Epub 2008 Mar 19.

PMID:
18503899
[PubMed - indexed for MEDLINE]
17.

Cancer statistics, 2008.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ.

CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.

PMID:
18287387
[PubMed - indexed for MEDLINE]
Free Article
18.

Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.

Malagari K, Chatzimichael K, Alexopoulou E, Kelekis A, Hall B, Dourakis S, Delis S, Gouliamos A, Kelekis D.

Cardiovasc Intervent Radiol. 2008 Mar-Apr;31(2):269-80. Epub 2007 Nov 13.

PMID:
17999110
[PubMed - indexed for MEDLINE]
19.

Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.

Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO.

J Vasc Interv Radiol. 2007 Jul;18(7):847-55.

PMID:
17609443
[PubMed - indexed for MEDLINE]
20.

Transcatheter and ablative therapeutic approaches for solid malignancies.

Liapi E, Geschwind JF.

J Clin Oncol. 2007 Mar 10;25(8):978-86. Review.

PMID:
17350947
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk